Table 2 Cause of death (AML or non-AML) in the main cohort (C1.X to C16.X)
Label | Iron/ICTa | AFS/OS (weeks)b | Final body weight (g) | Final liver weight (g) | Final spleen weight (mg) | Diagnosisc |
|---|---|---|---|---|---|---|
AML | ||||||
C3.3 | 7.5/0 | 35.8/37.1 | 33.5 | 2.53 | 260 | Monocytic leukemia |
C3.6 | 7.5/0 | 54.0/57.0 | 45.0 | – | – | Myeloid leukemiad |
C3.7 | 7.5/0 | 41.0/43.0 | 36.3 | – | – | Myeloid leukemiad |
C4.1 | 7.5/0 | 58.7/60.0 | 47.1 | 3.83 | 1085 | Monocytic leukemia |
C4.5 | 7.5/0 | 25.4/27.7 | 29.0 | 2.22 | 367 | Monocytic leukemia |
C10.1 | 7.5/10 | 31.3/35.0 | 31.6 | 7.29 | 1560 | Monocytic leukemia |
C11.4 | 7.5/40 | 37.3/38.3 | 34.1 | 3.64 | 1609 | Monocytic leukemia |
C11.5 | 7.5/40 | 63.1/69.0 | 40.7 | 2.06 | 86 | Myeloid leukemiae |
C12.5 | 7.5/40 | 36.3/41.6 | 36.4 | 2.01 | 930 | Myelomoncytic leukemia |
C6.1 | 15/0 | 55.7/57.0 | 42.9 | 3.94 | 789 | Monocytic leukemia |
C6.5 | 15/0 | 52.7/54.0 | 52.2 | 4.01 | 579 | Myeloid leukemiad |
C7.4 | 30/0 | 67.1/67.1 | 58.9 | 3.42 | 548 | Myelomoncytic leukemia |
C13.3 | 30/10 | 42.1/45.0 | 36.9 | 3.80 | 742 | Myeloid leukemiad |
C13.4 | 30/10 | 33.3/36.4 | 33.1 | 6.01 | 1170 | Monocytic leukemia |
C14.2 | 30/10 | 55.6/55.6 | 41.3 | 3.32 | 293 | Myeloid leukemiad |
Non-AML (censored) | ||||||
C1.4 | 0/0 | -−−/56.6 | 43.9 | 2.04 | 97 | Other |
C2.4 | 0/0 | -−−/50.0 | 49.9 | 2.12 | 1380 | Metastasized tumor |
C4.4 | 7.5/0 | -−−/16.7 | 37.2 | 1.46 | 63 | Other |
C10.2 | 7.5/10 | -−−/69.3 | 51.8 | 1.78 | 80 | Other |
C10.5 | 7.5/10 | -−−/68.6 | 45.5 | 6.30 | 175 | Liver tumor |
C12.1 | 7.5/40 | -−−/69.1 | 35.6 | 1.13 | 140 | Lung tumor |
C5.1 | 15/0 | -−−/67.1 | 52.0 | 2.88 | 187 | Abdominal tumor |
C7.3 | 30/0 | -−−/52.6 | 37.3 | – | – | Other |
C8.5 | 30/0 | -−−/39.6 | 28.4 | 2.08 | 87 | Other |
C15.1 | 30/40 | -−−/54.6 | 38.9 | 2.71 | 421 | Lymphoid neoplasm |
C15.2 | 30/40 | -−−/31.6 | 29.2 | 1.88 | 89 | Liver tumor |
C15.4 | 30/40 | -−−/44.0 | 60.8 | 3.87 | 205 | Bone tumor |
C16.2 | 30/40 | -−−/67.4 | 58.0 | 3.40 | 389 | Abdominal tumor |